Brokerages Set Chemed Corporation (NYSE:CHE) Target Price at $574.25

Chemed Corporation (NYSE:CHE) has received a consensus recommendation of “Moderate Buy” from the six research firms that are covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $574.25.

Several analysts have issued reports on CHE shares. Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, October 8th. Royal Bank Of Canada lowered their price objective on Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a research note on Monday, November 10th. Finally, Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Thursday, October 30th.

Chemed Stock Up 1.5%

CHE opened at $458.70 on Friday. Chemed has a twelve month low of $408.42 and a twelve month high of $623.60. The company’s 50-day moving average price is $435.31 and its two-hundred day moving average price is $444.55. The stock has a market cap of $6.50 billion, a price-to-earnings ratio of 24.26, a PEG ratio of 2.20 and a beta of 0.44.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Tuesday, October 28th. The company reported $5.27 EPS for the quarter, missing analysts’ consensus estimates of $5.39 by ($0.12). Chemed had a return on equity of 25.89% and a net margin of 11.02%.The company had revenue of $624.90 million during the quarter, compared to the consensus estimate of $626.04 million. During the same period last year, the firm posted $5.64 EPS. The company’s revenue for the quarter was up 3.1% compared to the same quarter last year. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. As a group, sell-side analysts anticipate that Chemed will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 5th. Investors of record on Monday, November 17th were paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Monday, November 17th. Chemed’s dividend payout ratio is presently 12.69%.

Insiders Place Their Bets

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Monday, November 24th. The shares were sold at an average price of $437.55, for a total value of $875,100.00. Following the completion of the transaction, the chief executive officer directly owned 94,197 shares in the company, valued at approximately $41,215,897.35. The trade was a 2.08% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 3.29% of the company’s stock.

Hedge Funds Weigh In On Chemed

A number of large investors have recently made changes to their positions in the stock. JPMorgan Chase & Co. raised its stake in shares of Chemed by 122.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 499,968 shares of the company’s stock valued at $223,856,000 after purchasing an additional 275,423 shares during the period. William Blair Investment Management LLC boosted its stake in Chemed by 13.6% in the 3rd quarter. William Blair Investment Management LLC now owns 385,124 shares of the company’s stock worth $172,435,000 after purchasing an additional 46,038 shares during the period. Epoch Investment Partners Inc. grew its holdings in Chemed by 29.4% during the 3rd quarter. Epoch Investment Partners Inc. now owns 307,275 shares of the company’s stock valued at $137,579,000 after buying an additional 69,878 shares in the last quarter. TD Asset Management Inc increased its position in shares of Chemed by 23.1% during the third quarter. TD Asset Management Inc now owns 301,831 shares of the company’s stock valued at $135,142,000 after buying an additional 56,546 shares during the period. Finally, Acadian Asset Management LLC lifted its holdings in shares of Chemed by 69.3% in the second quarter. Acadian Asset Management LLC now owns 250,722 shares of the company’s stock worth $122,056,000 after buying an additional 102,597 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.